PHORMED ANNOUNCES ARDS STUDY RESULTS ...Middle East

PR Newswire - News
PHORMED ANNOUNCES ARDS STUDY RESULTS
CENTURY CITY, Calif., Aug. 3, 2022 /PRNewswire/ -- PhorMed Inc, a Nevada Corporation ("PhorMed" or the "Company"), is a privately held clinical stage biopharmaceutical company. The Company's study drug RP-323 is in an on-going acute respiratory distress syndrome (ARDS) study. ARDS is a...

Hence then, the article about phormed announces ards study results was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( PHORMED ANNOUNCES ARDS STUDY RESULTS )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News